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Abstract
Objective—To determine whether a brief intervention for children with functional abdominal
pain and their parents' responses to their child's pain resulted in improved coping 12 months later.
Design—Prospective, randomized, longitudinal study.
Setting—Families were recruited during a 4-year period in Seattle, WA and Morristown, NJ.
Participants—200 children with persistent functional abdominal pain and their parents.
Interventions—A 3-session social learning and cognitive behavioral therapy intervention or an
education and support intervention.
Main outcome measures—Child symptoms and pain coping responses were monitored using
standard instruments, as was parental response to child pain behavior. Data were collected at
baseline and after treatment (1 week and 3, 6, and 12 months after treatment). This article reports
the 12-month data.
Results—Relative to children in the education and support group, children in the social learning
and cognitive behavioral therapy group reported greater baseline to 12-month follow-up decreases
in gastrointestinal symptom severity (estimated mean difference = -0.36, CI = -0.63, -0.01) and
greater improvements in pain coping responses (estimated mean difference = 0.61, CI = 0.26,
1.02). Relative to parents in the education and support group, parents in the social learning and
cognitive behavioral therapy group reported greater baseline to 12-month decreases in solicitous
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responses to their child's symptoms (estimated mean difference = -0.22, CI = -0.42, -0.03) and
greater decreases in maladaptive beliefs regarding their child's pain (estimated mean difference =
-0.36, CI = -0.59, -0.13).
Conclusions—Results suggest long-term efficacy of a brief intervention to reduce parental
solicitousness and increasing coping skills. This strategy may be a viable alternative for children
with functional abdominal pain.
Trial registration—ClinicalTrials.gov Identifier #NCT00494260
Long term maintenance of treatment gains is an important goal of any treatment trial.
Similarly, ease of administration (i.e., brevity and minimal invasiveness) is also a desirable
treatment characteristic, particularly in pediatric practice. However, the demonstration of
both of these characteristics often is not present in many studies. The present investigation
studied the long term maintenance of beneficial effects achieved in a brief, minimally
invasive, intervention for abdominal pain.
Abdominal pain is the most common recurrent pain complaint of childhood, and one often
frequently seen by pediatricians.1,2 Organic disease etiology is rarely identified in medical
evaluations of childhood abdominal pain, and thus most children with these persistent
complaints meet criteria for pediatric functional abdominal pain (FAP). FAP is defined as
episodic or continuous abdominal pain without evidence of an inflammatory, anatomicl,
metabolic, or neoplastic process that explains the patient's symptoms.3 Children with FAP
have increased psychosocial impairment, functional disability, health care utilization, and
emotional distress; their parents also report decreased quality of life.4-7 Children with FAP
are also at risk for continued symptoms as they age and transition to adulthood,6 and greater
risk (in comparison to their well-child peers) for the development of irritable bowel
syndrome,8 and chronic pain.9
Study description
We have reported on a prior study that10 tested the efficacy of an intervention (social
learning and cognitive behavior therapy [SLCBT]) that (1) taught children and their parents
cognitive behavioral strategies for managing the child's symptoms of FAP, and (2) taught
parents social learning strategies to reduce solicitous responses to illness behavior in their
children and to model and reinforce healthier ways for their children to respond to
gastrointestinal discomfort. Social learning theory, and cognitive behavior therapy, a clinical
derivative of this theory, maintains that an individual's behavior and thoughts (about
physical sensations, pain, or anything) are strongly influenced by the individual's learning
history - by the responses the individual has had to prior behavior and thoughts. Prior
research4,5,11-21 indicated that a cognitive behavioral approach aimed at changing parental
responses to their children's pain might improve the symptoms of FAP. This randomized
controlled trial showed that at a six month follow-up, parents in the SLCBT group (relative
to those in an education/support [ES] group) reported greater baseline to follow-up
reductions in their child's pain, their own solicitous responses to their child's pain reports,
and the perceived threat of their child's pain. Children in the SLCBT group, moreover,
reported greater baseline to follow-up increases in pain minimization, the ability to distract
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themselves, and the ability to ignore their pain relative to children in the ES group. Although
these findings showed promise, the stability of the outcomes of brief psychosocial
interventions such as these over time is an important question that needs to be addressed.
Thus, the goal of the present study was to test whether the positive results of this brief
intervention would be maintained at a 1-year follow-up. An earlier study reported on data
collected through six months, and the present study describes procedures used through the
12-month post-treatment data collection period.
Study Participants
Participants in the randomized controlled trial included 200 FAP parent-child dyads.
Families were recruited during a 4-year period via physician referral and community flyers
from pediatric gastrointestinal clinics in Seattle, Washington (Seattle Children's Hospital
and local area clinics) and Morristown, New Jersey (Atlantic Health System). As noted in
the article by Levy et al.,10 eligible children had experienced 3 or more episodes of recurrent
abdominal pain during a 3-month period, were 7 to 17 years old, and had cohabited with
their parent in the study for the past 5 years or, in cases of divided custody, at least half of
the child's lifetime. Exclusion criteria were chronic disease, lactose intolerance, major
surgery in the past year, organic evidence of abdominal pain, non-English speaking ability,
and developmental disability that impaired the ability to respond.
Design and procedure
The study design was prospective, randomized and longitudinal (NCT00494260).
Assessments were completed at baseline and 1 week, 3 months, 6 months, and 12 months
after treatment. Children completed all assessments via telephone with nurse assessors who
were masked to treatment assignment. Parents completed all assessments via mail (pencil-
and-paper). Randomization followed completion of baseline questionnaires. Patients were
stratified into 2 groups based on the child's age at enrollment (7-11 years and 12-17 years).
The 2 conditions consisted of 3 approximately 1-hour, in-person sessions with 1 of 14
trained therapists (master's degree or higher) spaced approximately 1 week apart. During
each session, most of the material was covered with children and their parents together, with
some time also allotted for each to be seen independently, primarily to allow each to discuss
privately any issue they wished. The experimental condition (SLCBT) was based on prior
research showing that solicitous responses by parents and parental modeling of illness
behavior is associated with more abdominal pain and other gastrointestinal symptoms.16 It
was also based on findings that maladaptive beliefs about the significance of pain and
coping strategies for dealing with pain have been associated with reported pain and
function.22-24 Parents and children were taught ways to think about and cope with pain in
ways that encouraged wellness (relaxation and maintenance of regular activities) rather than
illness behavior. The second condition (ES), designed to be a time and attention control
condition, provided information on the gastrointestinal system and nutrition. Care was taken
to include homework assignments, which required similar time and effort as in the SLCBT
condition. Further detail can be found in the article by Levy et al.10
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Measures completed by parents and children
Faces Pain Scale-Revised (FPS-R25)
The FPS-R consists of 6 hand-drawn faces showing gradual increases in pain expression
from left to right. Children are asked to choose the face that best describes their current pain;
parents independently make the same rating with respect to their child. Scores can range
from 0-10 with higher values indicative of greater pain.
Children's Somatization Inventory (CSI26,27)
The CSI is a reliable and valid measure of children's somatic symptoms. We focused on the
7 items assessing gastrointestinal symptoms: nausea, constipation, loose bowel movements
or diarrhea, abdominal pain, vomiting, feeling bloated or gassy, and food making you sick.
Children are asked to rate each item with respect to severity during the past week, using a
using a 0- to 4-point (not at all to a whole lot) scale. Parents make the same set of ratings
with respect to their child's gastrointestinal symptoms.
Measures completed by parents
Demographics
A standard form assessed basic demographic characteristics of both parents and children.
Functional Disability Inventory (FDI28)
The FDI assesses the effect of physical health on children's physical and psychosocial
functioning. In the parent-report version, parents are asked to rate the extent to which
activities such as “walking to the bathroom” have been difficult or posed a physical
challenge for their child during the past week. Ratings are made on a 0- to 4-point (no
trouble to impossible) scale.
Adults' Responses to Children's Symptoms (ARCS14,29)
The ARCS assesses parents' self-reported responses to their children's abdominal pain
behaviors. We focused on the 15-item protectiveness subscale, a measure of solicitousness
or the extent to which parents respond to their children's pain behaviors with sympathy,
attention, discouragement of activity, and relief from responsibility. Items such as, “When
your child has a stomachache, how often do you tell him/her that s/he doesn't have to finish
all of his/her homework?” are rated on a 0- to 4-point (never to always) scale.
Pain Beliefs Questionnaire (PBQ30)
The 32-item PBQ was developed to assess parents' beliefs about various aspects of their
child's abdominal pain. Items such as, “My child's stomachaches go on forever” are rated on
a 0- to 4-point (not at all true to very true) scale. We focused on the perceived threat
subscale, a mean of the condition seriousness, condition duration, condition frequency,
episode intensity, and episode duration subscales.
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Measures completed by children
Pain Response Inventory (PRI31)
The PRI assesses children's responses to pain. Items such as, “When you have a
stomachache, how often do you… think to yourself that it's never going to stop?” are rated
on a 0- to 4-point (never to always) scale. The measure includes 13 subscales. We focused
on 3 reflective of the SLCBT intervention: catastrophizing, distract/ignore, and minimizing
pain.
Statistical analysis
Statistical analyses were conducted using SAS statistical software, version 9.2 (SAS
Institute, Inc). General linear mixed-effects models (GLMMs) for repeated measures data
were applied to examine the effects of treatment over time on each of the primary and
process-oriented variables. Analyses were performed using an intent- to- treat approach.
GLMMs allow for the specification of a covariance structure that accounts for within-
subject correlation over time yielding more precise estimates and standard errors. Unlike
traditional approaches to analysis of repeated measures that eliminate those with missing
data, GLMMs use all available data to generate valid maximum likelihood parameter
estimates when the data are assumed to be missing at random. Each repeatedly measured
dependent variable was regressed on time, treatment condition, and the interaction of time
and treatment, with baseline as the time referent. Child age and sex were included as
covariates in the models. The parameter estimates from the interaction terms represent
estimates of treatment effects at 12 months (change from baseline to 12 months in the
dependent variable in terms of standard deviation units). Maintenance of treatment effects
from 6 to 12 months were also calculated and reported. To determine the significance of the
6 contrasts tested for each outcome, we applied the method by Benjamini and Hochberg32
for controlling the false discovery rate at 5%. To quantify the effects of treatment on the
outcomes, we calculated the Cohen effect size d. Cohen d reflects the effect of the
intervention on the outcome in the scale of standard deviation units, and values are
interpreted as low (d = .20), moderate (d = .50), and high (d = .80). A priori power analysis
based on a 2-sided independent t test at an uncorrected α of .05 indicated 100 cases per
group were required to detect a moderate effect size (Cohen d = .40) with adequate power
(1-β = .80).
Although this article reports 6-month to 12-month and baseline to 12-month changes, all
data (baseline and 1 week, 3 weeks, 6 months and 12 months after treatment) were included
in the model for estimation precision. Given our hypotheses regarding greater improvement
in the SLCBT group compared with the ES group, we specified 6 a priori contrasts to be
tested using the estimates from each model: within-group change for SLCBT from 6 months
to 12 months and baseline to 12 months, within-group change for ES from 6 months to 12
months and baseline to 12 months, and between-group differences in these changes.
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Demographic characteristics of the 200 enrolled children were as follows: mean (SD) age,
11.2 (2.6) years; female sex, 72.5%; and white race, 89.0%. Demographic characteristics of
parents were as follows: mean (SD) age = 43.7 (6.3) years; female sex, 94.0%; white race,
93.0%; having earned a 4-year college degree, 60.0%; employed full or part time, 68.5%;
and married or cohabitating with a partner, 77.0%. These characteristics did not differ as a
function of treatment condition (P = .66 for child age, .64 for child sex, .14 for child race, .
87 for parent age, .55 for parent sex, .66 for parent race, .98 for parent education, .60 for
employment status, and .83 for marital status).
Figure 1 contains a CONSORT diagram illustrating study flow from eligibility assessment
to enrollment to intervention and follow-up assessment. A total of 87.0% of SLCBT
participants and 89.0% of ES participants completed all 3 intervention sessions (P = .66).
Intervention completers and no-completers did not differ with respect to child sex, child age,
or child baseline pain levels (P = .50 for sex, .11 for age, and .75 for child pain levels).
Table 1 presents raw means and standard deviations as a function of time (baseline, 6
months, and 12 months) and treatment condition. Table 2 presents results from the GLMMs
for the outcome and process variables. Average mean differences with 95% confidence
intervals are noted in the following sections and interpreted using Cohen effect size d.
Primary outcomes
Pain—As reported in the article by Levy et al.,10 parents in the SLCBT group reported
greater reductions in their child's pain from baseline to 6 months relative to parents in the ES
group. The present analysis shows that this effect was maintained to 12 months in that
parents in the SLCBT condition reported a significant and moderate reduction in their child's
pain from baseline to 12 months (average mean difference and 95% confidence interval =
-1.19 (-1.81, -.58)), while parents in the ES condition evidenced little change over time, -.43
(-1.08, .23). Overall, the between-group effect was small, -.77 (-1.66, .13). Children in both
treatment conditions reported significant within-group baseline to 12 month improvement in
self-reported pain, -1.50 (-2.02, -.98) for SLCBT and -.95 (-1.49, -.40) for ES; as with
parent-report, the between-group effects were small, -.55 (-1.31, .20) and did not attain
significance.
Functional disability—Functional disability as reported by parents significantly
decreased (improved) from baseline to 12 months in both treatment conditions, parallel to
the 6-month findings10, -.51, (-.72, -.29) for SLCBT, a large effect, and -.34 (-.57, -.11) for
ES, a moderate effect; the between-group effect was not significant, -.16 (-.48, .15).
GI symptom severity—Parents' ratings of their child's GI symptoms significantly
improved from baseline to 12 month-follow-up in both treatment groups, -.55 (-.74, -.35) for
SLCBT and -.28 (-.50,-.07) for ES. The between-group effect size difference was small to
moderate -.26 (-.55, .03) and did not reach statistical significance. Children's ratings of their
own GI symptoms also improved from baseline to 12 months in both groups, but with
significantly greater improvement among children in the SLCBT condition (-.65 (-.83,-.09)
Levy et al. Page 6






















for SLCBT, a large effect; -.29 (-.48,-.10) for ES, a moderate effect; and -.36 (-.63, -.01) for
the mean difference between groups).
Process variables
Parental solicitousness—As predicted, parents in the SLCBT condition reported greater
baseline to 12 month reductions in solicitousness as compared to parents in the ES
condition, -.56 (-.70,-.43) for SLCBT and -.34 (-.49,-.19) for ES. The between-group
difference was small, -.22 (-.42, -.03). As seen in Table 2, this represents a further reduction
in solicitousness from 6 to 12 months in the SLCBT condition.
Pain beliefs—Parallel to the 6 month findings,10 parents in the SLCBT condition reported
significantly greater baseline to 12 month reductions in the perceived threat of their child's
pain, -.64 (-.80,-.49), a large effect relative to parents in the ES condition, -.28 (-.45,-.12), a
small-moderate effect. The between-group effect size difference was significant and
moderate, -.36 (-.59, -.13).
Coping skills—Children in the SLCBT condition reported significantly greater baseline to
12 month follow-up increases in the ability to minimize their pain relative to children in the
ES condition; .68 (.45, .98) for SLCBT and .07 (-.20, .34) for ES, with a moderate between-
group difference, .61 (.26, 1.02). Findings were similar for the ability to distract oneself and
ignore the pain; .30 (.09, .52) for SLCBT, -.08 (-.30, .15) for ES, and .38 (.07, .70) for the
between-group effect size difference. Catastrophizing lessened/improved over time in both
groups; -.76 (-.97, -.54) for SLCBT and -.54 (-.76, -.32) for ES; the difference between
groups was small, -.21 (-.52, .09).
Comment
This study demonstrated that after a twelve month follow-up period, children in the
cognitive behavioral condition (SLCBT) evidenced greater baseline to 12 month follow-up
decreases in gastrointestinal (GI) symptom severity and greater improvements in pain
coping responses than children randomly assigned to a comparison condition which
controlled for time and attention. Similarly, parents in the cognitive behavioral condition
reported greater baseline to 12 month decreases in solicitous responses to their child's
symptoms, and greater decreases in maladaptive beliefs regarding their child's pain than
parents who were randomly assigned to the time and attention comparison condition. Thus
the SLCBT condition continued to demonstrate significant improvements over the ES
condition in several key variables.
There are a number of questions which would be logical next steps to address in subsequent
research. Certainly one direction worth exploring would be to determine whether the effects
of the intervention could be strengthened. An intervention of longer duration, or one with
booster sessions, might produce stronger effects. However, this line of exploration should
strive to maintain a primary goal of brief intervention research: to develop strategies that are
cost-effective and easily implemented in most clinical settings. Another option might
consider using this model in a small group setting to make it more cost effective. Further
research should thus identify strategies that optimally balance efficacy of therapy with
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minimizing costs and resource utilization. Relatedly, it would be worthwhile to assess
economic and other benefits of the intervention, including fewer missed parent work days or
lowered health care utilization. Another important line of investigation worth pursuing
would be to identify, and then target, the most active components of the intervention. One
possibility is that several of the process variables such as parental solicitousness, pain
beliefs, and coping skills mediated changed in child outcome variables. It would be of
interest, for example, to isolate the effects of changing parental responses from those of
changing child coping or cognitions. Once identified, focusing treatment on the most potent
strategies could help improve both efficacy and efficiency of interventions. Relatedly, some
research has found both a link between functional abdominal pain and anxiety,33 as well as
evidence for the effectiveness of CBT in treating childhood anxiety.33 Therefore, examining
and perhaps focusing on anxiety among these functional abdominal pain patients might be
one worthwhile direction for this line of research.
Limitations
Despite every effort at randomization, pre-treatment differences were observed for child-
and parent-reported child pain. Accordingly, significant magnitude of effect size change for
the SLCBT group on these measures needs to be considered in light of potential regression
to the mean. Because the analysis was focused on magnitude of improvement from baseline
and we only had one baseline assessment, baseline differences were not “controlled for” in
the statistical model. Future studies should obtain two baseline assessments to covary out
any pretreatment differences while still examining change from baseline. Additionally,
participants assigned to the interventions should be stratified on these pain measures.34,35
Conclusions
This study is the largest, to date, randomized controlled trial with a lengthy follow-up period
of a psychological intervention for children with functional abdominal pain. It demonstrates
maintenance of treatment gains on a number of outcome measures for at least 12 months
following a very brief intervention (three sessions) for childhood functional abdominal pain.
The data from this study provide some evidence for pediatricians to utilize in beginning to
“make the case” to parents about the importance of psychological factors. Further research
in this area may help strengthen this case. Nevertheless, for the present, given the relative
low cost of this intervention, pediatricians should consider the incorporation of these
strategies into their treatment plan for children with this common complaint. The
opportunity that some pediatric practices have to co-locate a mental health specialist in an
office or clinic may also facilitate making this therapy more available.
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Figure 1. Consort Diagram
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Table 1
Raw means and standard deviations for outcome and process variables as a function of
time point and treatment condition
Baseline 6 months 12 months
N 200 154 141
Parent-report
Child current pain (FPS-R)
 SLCBT 2.04 (2.18) 0.99 (1.82) 0.88 (1.86)
 ES 1.41 (1.91) 1.35 (2.45) 0.94 (1.78)
Child functional disability (FDI)
 SLCBT 0.86 (0.77) 0.42 (0.67) 0.33 (0.51)
 ES 0.81 (0.71) 0.51 (0.68) 0.45 (0.63)
Child GI symptom severity (CSI)
 SLCBT 1.25 (0.71) 0.68 (0.54) 0.68 (0.63)
 ES 1.10 (0.69) 0.78 (0.66) 0.81 (0.72)
Parental solicitousness (ARCS)
 SLCBT 1.14 (0.53) 0.67 (0.52) 0.57 (0.51)
 ES 1.18 (0.57) 0.96 (0.50) 0.80 (0.49)
Perceived threat (PBQ)
 SLCBT 2.07 (0.59) 1.44 (0.67) 1.41 (0.69)
 ES 2.00 (0.53) 1.73 (0.67) 1.68 (0.58)
Child-report
Child current pain (FPS-R)
 SLCBT 2.44 (2.42) 0.97 (1.40) 0.93 (1.42)
 ES 1.63 (1.85) 0.74 (1.41) 0.70 (1.53)
Child GI symptom severity (CSI)
 SLCBT 1.28 (0.75) 0.70 (0.56) 0.64 (0.68)
 ES 1.09 (0.61) 0.70 (0.62) 0.79 (0.71)
Catastrophizing (PRI)
 SLCBT 1.63 (0.86) 0.99 (0.77) 0.89 (0.78)
 ES 1.56 (0.87) 1.06 (0.70) 1.03 (0.76)
Distract/Ignore (PRI)
 SLCBT 2.32 (0.79) 2.56 (0.67) 2.61 (0.82)
 ES 2.31 (0.81) 2.44 (0.73) 2.19 (0.79)
Minimizing pain (PRI)
 SLCBT 1.15 (0.88) 1.78 (0.88) 1.84 (0.89)
 ES 1.48 (0.90) 1.57 (0.93) 1.56 (0.90)
Note. The SLCBT and ES groups differed at baseline on three measures: parent-reported child current pain (p = .035), child-reported current pain
(p = .009), and child-reported minimizing pain (p = .01).
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